Department of Cardiac Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Fujian Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fuzhou, Fujian 350001, China.
J Interv Cardiol. 2021 Aug 13;2021:5662697. doi: 10.1155/2021/5662697. eCollection 2021.
The objective of this investigation was to study the early efficacy of in situ fenestration with triple chimney technique for high-risk type A aortic dissection patients.
This study included 24 patients who were treated by in situ fenestration with TCT for high-risk TAAD between January 2018 and December 2019. Multiple comorbidities or preoperative critical conditions rendered patients ineligible for open surgery, but all patients that were evaluated and considered had to undergo operation. By analyzing the regular follow-up data, the early postoperative efficacy of the patients was evaluated.
The average age of the 24 patients was 65.4 ± 9.3 years. The success rate of the operation was 100%, as all the patients were discharged successfully. There were no serious neurological complications or persistent endoleakage. The mean follow-up time was 21.4 ± 6.9 months. The patency rate of all branching stents was 100%, with no stent displacement, stenosis, or blockage observed. While none presented with type I endoleakage, one patient (4.2%) presented asymptomatic type II endoleakage around the left subclavian artery stent. Currently, 23 of the 24 patients remain alive.
Initial results are encouraging with TCT for high-risk TAAD. However, due to its high selectivity and potential complexity related to surgical risks, the mid- and long-term efficacy of this technique remains unknown. For patients who are eligible for open heart surgery, we still recommend it be performed.
本研究旨在探讨原位开窗联合三分支技术(TCT)治疗高危型 A 型主动脉夹层(TAAD)的早期疗效。
本研究纳入了 2018 年 1 月至 2019 年 12 月期间采用原位开窗联合 TCT 治疗高危 TAAD 的 24 例患者。由于存在多种合并症或术前危急情况,这些患者不符合开放手术的条件,但所有评估后认为需要手术的患者均被纳入研究。通过分析定期随访数据,评估患者的术后早期疗效。
24 例患者的平均年龄为 65.4±9.3 岁。手术成功率为 100%,所有患者均成功出院。无严重神经并发症或持续性内漏。平均随访时间为 21.4±6.9 个月。所有分支支架的通畅率均为 100%,无支架移位、狭窄或闭塞。虽然无一例出现 I 型内漏,但有 1 例(4.2%)患者左锁骨下动脉支架周围出现无症状的 II 型内漏。目前,24 例患者中 23 例存活。
TCT 治疗高危 TAAD 的初步结果令人鼓舞。然而,由于其高度选择性和与手术风险相关的潜在复杂性,该技术的中远期疗效仍不清楚。对于符合心脏直视手术条件的患者,我们仍建议进行该手术。